PLI 2.0 for Medical Devices Opens With Rs 2,700 Crore

The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, called for fresh applications on 10 November 2026 under the Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices, known as PLI-MD. The scheme has been carried forward up to 2035-36, and an outlay of roughly Rs 2,700 crore is available for the new round. Applications will be filed on an online portal that the department said would go live within the next ten days.

What the first phase delivered

The scheme began in 2021-22. Since then more than 60 high-end devices and components have started being made in India, among them X-ray tubes and detectors, a 1.5T MRI machine, LINAC, CT scanners, mammography units, Cathlab systems, orthopaedic and cardiac implants and dialyzers. Output under the scheme has crossed Rs 16,000 crore in value.

Four target segments and their incentives

Successful applicants get three years to build their plants in any of these segments, and the incentive rate tapers over the period. In the consumables and disposables segment the aim is scale and world-class quality, while in the two high-end segments priority goes to integrating the value chain so that devices made in India become more competitive. The push on critical components is also expected to help micro, small and medium enterprises.

Easier rules this time

• The minimum sales threshold that had to be met before claiming an incentive has been removed.
• The minimum investment requirement has been reduced.
• An applicant may file any number of applications across one or more segments.
• The application window will stay open continuously over a long stretch rather than for a short period.

The department described the new round as PLI-MD 2.0 and tied it to Atmanirbhar Bharat and Make in India, with the stated aims of building home-grown supply chains, drawing investment, creating jobs, improving quality, lowering device prices and lifting India’s standing in high-end medical technology. The scheme now wants deep manufacturing of equipment that the country does not make at all, such as 3T MRI machines, PET-CT scanners, ultrasound probes and consoles, and high-throughput in-vitro diagnostic analysers.